2022•International Journal for Research in Applied Science and Engineering TechnologyOpen access

The Effectiveness of The Treatment of Idiopathic Thrombocytopenic Purpura with Modern Drugs

Madasheva Anajan Gazkhanovna, Salimov Akmaljon Fatullo Ugli, Chorieva Lobarkhon Zayniddin Kizi

Abstract

Abstract: This article discusses the effectiveness of treatment of idiopathic thrombocytopenic purpura with modern drugs and its new methods. Primary immune thrombocytopenia, commonly referred to as idiopathic thrombocytopenic purpura (ITP), is an acquired autoimmune disease characterized by isolated thrombocytopenia. Keywords: treatment, idiopathic thrombocytopenic purpura, modern drugs, new methods, clinical fetures, disease

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Thrombocytopenic purpura, Medicine, Disease, Purpura (gastropod), Immune system, Immunology, Dermatology, Internal medicine